版本:
中国

BRIEF-Gemphire Therapeutics announces $12.5 mln financing - SEC Filing

March 10 Gemphire Therapeutics Inc :

* Entered into securities purchase agreement for private placement with "a select group of accredited investors" - SEC Filing

* Private placement will consist of 1.3 million units sold at price of $9.47 per unit for gross proceeds of about $12.5 million

* Intends to fund development costs, phase 2 clinical trial of gemcabene, manufacturing related activities for gemcabene Source text: (bit.ly/2lL4Pkx) Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐